As new GLP-1 medications gain popularity for weight loss, experts are sounding the alarm about a disturbing trend: the emergence of ‘agonorexia.’ This term refers to a new wave of eating disorders and body image issues fueled by the widespread use of these drugs, which are changing not only how people eat, but also how they think about food and their bodies.
What is ‘agonorexia’?
‘Agonorexia’ is a term coined by clinicians to describe the obsessive behaviors and restrictive eating patterns developing in some users of GLP-1 medications. These drugs, originally designed for diabetes management, are now being prescribed off-label for weight loss, leading to a surge in popularity among those seeking rapid results.
Key Concerns
- GLP-1s are changing the landscape of eating disorders, introducing new risks and complications.
- Patients report increased anxiety around food, compulsive calorie tracking, and unhealthy weight loss goals.
- Experts warn that social media and celebrity endorsements are amplifying dangerous body image standards.
Expert Opinions
Medical professionals emphasize the need for caution, noting that while GLP-1s can be effective for some, they may trigger or worsen disordered eating in vulnerable individuals. Ongoing research is needed to fully understand the long-term psychological and physical impacts.
Learn More
Support responsible health choices: If you or someone you know is struggling with eating disorders or body image issues, consider seeking professional help. For additional resources and information about healthy approaches to wellness, visit our recommended partner: Wellness Support Resource.